The XPC splice acceptor site variant, c.2251-1G > C, that was detected in two breast cancer patients (BRB114 & BRB161), is an ancient founder variant that is thought to have occurred ~ 800 years ago in the Bantu population of West-Central Africa52. Here, XPC is linked to breast carcinoma.